AnaBios
Melanie Fan is a Principal with Ampersand Capital Partners, having joined in 2018. Previously, she worked at Frazier Healthcare and UBS Investment Bank focusing on deals with middle-market healthcare companies. Melanie’s current and past board seats include StageBio, Alliance Pharma, Sterling Medical Devices and LakePharma.
Melanie holds a B.S. in Economics and Statistics from Duke and a M.B.A. in Health Care Management from Wharton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AnaBios
AnaBios generates highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs, thereby reducing the time and expense related to clinical trial failures.